Skip to content
10-Q

Quarterly Report

AXIM BIOTECHNOLOGIES, INC. AXIM

0001096906-23-002238

← back to feed
Filed
Nov 20, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Oct 17, 2023 237.65M sh
Shares Diluted Q3 2023 · Sep 30, 2023 478.51M sh
Capex Q3 2023 · Sep 30, 2023 $0
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$1.05M
Stockholders Equity Q3 2023 · Sep 30, 2023 −$5.96M
Stockholders Equity Q3 2023 · Jun 30, 2023 −$9.75M
Stockholders Equity Q3 2023 · Mar 31, 2023 −$6.16M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$4.83M
Current Liabilities Q3 2023 · Sep 30, 2023 $4.28M
Current Liabilities Q3 2023 · Dec 31, 2022 $3.39M
Total Liabilities Q3 2023 · Sep 30, 2023 $10M
Total Liabilities Q3 2023 · Dec 31, 2022 $9.04M
Current Assets Q3 2023 · Sep 30, 2023 $23.22K
Current Assets Q3 2023 · Dec 31, 2022 $103.98K
Total Assets Q3 2023 · Sep 30, 2023 $4.04M
Total Assets Q3 2023 · Dec 31, 2022 $4.21M
Eps Diluted Q3 2023 · Sep 30, 2023 $0.00
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.03
Eps Basic Q3 2023 · Sep 30, 2023 $0.00
Eps Basic Q3 2023 · Sep 30, 2023 −$0.03
Sga Expense Q3 2023 · Sep 30, 2023 $456.65K
Sga Expense Q3 2023 · Sep 30, 2023 $1.61M
Rd Expense Q3 2023 · Sep 30, 2023 $34.71K
Rd Expense Q3 2023 · Sep 30, 2023 $89.12K
Rd Expense Q3 2023 · Dec 31, 2021 $284.87K
Net Income Q3 2023 · Sep 30, 2023 $328.47K
Net Income Q3 2023 · Sep 30, 2023 −$6.16M
Net Income Q3 2023 · Jun 30, 2023 −$3.72M
Net Income Q3 2023 · Mar 31, 2023 −$2.76M
Operating Income Q3 2023 · Sep 30, 2023 −$588.54K
Operating Income Q3 2023 · Sep 30, 2023 −$2M
Revenue Q3 2023 · Sep 30, 2023 $9.58K
Revenue Q3 2023 · Sep 30, 2023 $26.66K